profile-img
Eric Feigl-Ding

@DrEricDing

Epidemiologist & health economist. Whistleblower. Faculty @NECSI. Fmr 16 years @Harvard. Early warnings: https://t.co/eNp7gjyhC0

calendar_today10-01-2009 11:01:33

74,7K Tweets

756,2K Followers

13,2K Following

Eric Feigl-Ding(@DrEricDing) 's Twitter Profile Photo
Eric Feigl-Ding
@DrEricDing

7 months ago

🧪APPROVED—The FDA has now authorized ’s new XBB-variant booster shot for use in all ages 12+. Anyone previously vaccinated with a vaccine (any brand) are eligible to receive one dose, and unvaccinated may receive 2 doses.
fda.gov/news-events/pr…

🧪APPROVED—The FDA has now authorized #Novavax’s new XBB-variant booster shot for use in all ages 12+. Anyone previously vaccinated with a #COVID19 vaccine (any brand) are eligible to receive one dose, and unvaccinated may receive 2 doses. #CovidIsNotOver fda.gov/news-events/pr…
account_circle
Eric Feigl-Ding(@DrEricDing) 's Twitter Profile Photo
Eric Feigl-Ding
@DrEricDing

7 months ago

2) Why is Novavax’s vaccine unique? For those not familiar, it is the only non-mRNA vaccine available in the US, and it offers potentially broader protection (earlier studies) against different variants.

account_circle